Inhibition of UBE2N in regulatory T-cells boosts immunity against cancer
Wanying Miao, Vaibhav Jain, Madison Han, Yingai Jane Jin, Georgia Marie Beasley, Daniel T. Starczynowski, Simon G. Gregory, Jennifer Y. Zhang
The paper shows that inhibiting UBE2N in Tregs enhances anti-tumor immunity without causing autoimmunity by converting Tregs into effector-like cells.
bioRxiv · Oct 22, 2024 · PreprintCancer Biology